| dc.creator |
Rintoul, RC |
|
| dc.creator |
Ritchie, AJ |
|
| dc.creator |
Edwards, JG |
|
| dc.creator |
Waller, DA |
|
| dc.creator |
Coonar, AS |
|
| dc.creator |
Bennett, M |
|
| dc.creator |
Lovato, E |
|
| dc.creator |
Hughes, V |
|
| dc.creator |
Fox-Rushby, JA |
|
| dc.creator |
Sharples, LD |
|
| dc.date |
2015-01-29T13:19:10Z |
|
| dc.date |
2014-09-20 |
|
| dc.date |
2015-01-29T13:19:10Z |
|
| dc.date |
2014 |
|
| dc.date.accessioned |
2022-05-25T14:53:05Z |
|
| dc.date.available |
2022-05-25T14:53:05Z |
|
| dc.identifier |
The Lancet, 383, pp. 1118 - 1127, 2014 |
|
| dc.identifier |
0140-6736 |
|
| dc.identifier |
http://www.sciencedirect.com/science/article/pii/S0140673614604189 |
|
| dc.identifier |
http://bura.brunel.ac.uk/handle/2438/10012 |
|
| dc.identifier |
http://dx.doi.org/10.1016/S0140-6736(14)60418-9 |
|
| dc.identifier.uri |
http://localhost:8080/xmlui/handle/CUHPOERS/172669 |
|
| dc.description |
Background: Malignant pleural mesothelioma incidence continues to rise, with few available evidence-based therapeutic options. Results of previous non-randomised studies suggested that video-assisted thoracoscopic partial pleurectomy (VAT-PP) might improve symptom control and survival. We aimed to compare efficacy in terms of overall survival, and cost, of VAT-PP and talc pleurodesis in patients with malignant pleural mesothelioma. |
|
| dc.format |
1118 - 1127 |
|
| dc.format |
1118 - 1127 |
|
| dc.language |
eng |
|
| dc.language |
en |
|
| dc.publisher |
Lancet Publishing Group |
|
| dc.relation |
The Lancet |
|
| dc.relation |
The Lancet |
|
| dc.subject |
Malignant pleural mesothelioma incidence |
|
| dc.subject |
Video-assisted thoracoscopic partial pleurectomy (VAT-PP) |
|
| dc.subject |
Symptom control |
|
| dc.title |
Efficacy and cost of video-assisted thoracoscopic partial pleurectomy versus talc pleurodesis in patients with malignant pleural mesothelioma (MesoVATS): An open-label, randomised, controlled trial |
|
| dc.type |
Article |
|